Evidence map›Paper›PMID 38203220›Full record

ReviewInternational journal of molecular sciences2023

Targeting Signalling Pathways in Chronic Wound Healing.

Lian Bonnici, Sherif Suleiman, Pierre Schembri-Wismayer, Analisse Cassar

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Marine-Derived Polyketides fromACS pharmacology & translational science · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. The Yin-Yang of Stress and Senescence: Integrated Stress Response and SASP Crosstalk in Stem Cell Fate, Regeneration, and Disease.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2026
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lian BonniciDepartment of Anatomy, University of Malta, MSD 2080 Msida, Malta.ORCID 0009-0006-6493-8673
Sherif SuleimanDepartment of Anatomy, University of Malta, MSD 2080 Msida, Malta.
Pierre Schembri-WismayerDepartment of Anatomy, University of Malta, MSD 2080 Msida, Malta.
Analisse CassarDepartment of Anatomy, University of Malta, MSD 2080 Msida, Malta.ORCID 0000-0003-3148-3810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic wounds fail to achieve complete closure and are an economic burden to healthcare systems due to the limited treatment options and constant medical attention. Chronic wounds are characterised by dysregulated signalling pathways. Research has focused on naturally derived compounds, stem-cell-based therapy, small molecule drugs, oligonucleotide delivery nanoparticles, exosomes and peptide-based platforms. The phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT), Wingless-related integration (Wnt)/β-catenin, transforming growth factor-β (TGF-β), nuclear factor erythroid 2-related factor 2 (Nrf2), Notch and hypoxia-inducible factor 1 (HIF-1) signalling pathways have critical roles in wound healing by modulating the inflammatory, proliferative and remodelling phases. Moreover, several regulators of the signalling pathways were demonstrated to be potential treatment targets. In this review, the current research on targeting signalling pathways under chronic wound conditions will be discussed together with implications for future studies.

Indexed as

ExosomesNanoparticlesHumansHypoxia-Inducible Factor 1Phosphatidylinositol 3-KinaseWound HealingHypoxia-Inducible Factor 1Phosphatidylinositol 3-Kinasechronic wound healingexosomesHIF-1naturally derived compoundsNotchNrf2oligonucleotide delivery nanoparticlespeptide-based platformsPI3K/AKTsignalling pathwayssmall molecules drugsstem-cell-based therapyTGF-βWnt/β-catenin

Identifiers

PMID38203220
PMCPMC10779022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.